Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-03T02:33:57.519Z Has data issue: false hasContentIssue false

14 - Management of vaginal bleeding in the acute clinical setting

Published online by Cambridge University Press:  05 July 2014

Natalie Am Cooper
Affiliation:
University of Birmingham, Birmingham Women’s Hospital
T Justin Clark
Affiliation:
Birmingham Women’s Hospital
Davor Jurkovic
Affiliation:
University College London
Roy Farquharson
Affiliation:
University of Liverpool
Get access

Summary

Introduction

Heavy vaginal bleeding is a common problem, accounting for approximately 70% of referrals to gynaecologists from primary care. Although this condition is usually encountered in an elective outpatient clinic setting, there are occasions when acute bleeding requires emergency hospital admission. Abnormal vaginal bleeding is the second most common reason for presentation to emergency gynaecology units after acute pelvic pain.

This chapter provides a comprehensive overview of non-pregnancy-associated conditions that might present with acute vaginal bleeding. General approaches to management are described, followed by information and advice on managing specific conditions, with key points to be elicited from the history, signs to search for during clinical examination and information on further investigations and treatment. Acute vaginal bleeding can also result from trauma to the genital tract, including trauma arising from sexual assault. Management of such injuries is discussed.

Acute presentation of vaginal bleeding

Abnormally heavy vaginal bleeding is usually uterine in origin (Box 14.1). A thorough clinical history should be taken with particular regard to previous menstrual problems, past investigations and medical or surgical treatment. Women often present with an acute-on-chronic history of heavy vaginal bleeding and may already be taking oral progestogens in a sporadic fashion. Contraceptive history is also relevant as long-acting reversible contraceptives, such as the levonorgestrel-releasing intrauterine system (Mirena®; Bayer Healthcare Pharmaceuticals Inc., Wayne, NJ, USA) or injectable or implanted progestogens, are often associated with breakthrough bleeding in the first few months of use, which can sometimes be heavy.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×